Cas:82424-54-2 methyl 4-amino-3-(4-methoxyphenyl)-1,2-thiazole-5-carboxylate manufacturer & supplier

We serve Chemical Name:methyl 4-amino-3-(4-methoxyphenyl)-1,2-thiazole-5-carboxylate CAS:82424-54-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

methyl 4-amino-3-(4-methoxyphenyl)-1,2-thiazole-5-carboxylate

Chemical Name:methyl 4-amino-3-(4-methoxyphenyl)-1,2-thiazole-5-carboxylate
CAS.NO:82424-54-2
Synonyms:methyl 3-(4-methoxyphenyl)-4-amino-5-isothiazolecarboxylate;Methyl 4-amino-3-(4-methoxyphenyl)isothiazole-5-carboxylate
Molecular Formula:C12H12N2O3S
Molecular Weight:264.30000
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:357.523ºC at 760 mmHg
Density:1.311g/cm3
Index of Refraction:1.611
PSA:102.68000
Exact Mass:264.05700
LogP:2.76870

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like methyl 3-(4-methoxyphenyl)-4-amino-5-isothiazolecarboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 4-amino-3-(4-methoxyphenyl)isothiazole-5-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl 3-(4-methoxyphenyl)-4-amino-5-isothiazolecarboxylate Use and application,Methyl 4-amino-3-(4-methoxyphenyl)isothiazole-5-carboxylate technical grade,usp/ep/jp grade.


Related News: Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. methyl 4-amino-3-(4-methoxyphenyl)-1,2-thiazole-5-carboxylate manufacturer With the onset of the DMF system for APIs, the concentration of the API industry will further increase. methyl 4-amino-3-(4-methoxyphenyl)-1,2-thiazole-5-carboxylate supplier The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG��s pharmaceutical business within the Corden Pharma platform. The companies�� goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed. methyl 4-amino-3-(4-methoxyphenyl)-1,2-thiazole-5-carboxylate vendor Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. methyl 4-amino-3-(4-methoxyphenyl)-1,2-thiazole-5-carboxylate factory With the onset of the DMF system for APIs, the concentration of the API industry will further increase.